Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ImmunoPrecise Antibodies Ltd. (IPA : NSDQ)

• Company Description    ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA. Number of Employees: 101

• Price / Volume Information    Yesterday's Closing Price: $1.31 Daily Weekly Monthly 20 Day Moving Average: 4,797,161 shares Shares Outstanding: 45.76 (millions) Market Capitalization: $59.95 (millions) Beta: 0.44 52 Week High: $1.31 52 Week Low: $0.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 94.82% 86.17% 12 Week 203.73% 159.43% Year To Date 218.19% 198.04%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3204-4464 Markham Street - Victoria,A1 V8Z 7X8 CAN ph: 250-483-0308 fax: - investors@immunoprecise.com http://www.immunoprecise.com

• General Corporate Information    Officers Jennifer Bath - President and Chief Executive Officer Mitch Levine - Chairman of the Board Kristin Taylor - Chief Financial Officer Chris Buyse - Director Barry A.Springer - Director Peer Information ImmunoPrecise Antibodies Ltd. (HLIS) ImmunoPrecise Antibodies Ltd. (AZTA) ImmunoPrecise Antibodies Ltd. (APYI) ImmunoPrecise Antibodies Ltd. (RNVA) ImmunoPrecise Antibodies Ltd. (HMSY) ImmunoPrecise Antibodies Ltd. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 45257F200 SIC: 2834 Fiscal Year Fiscal Year End: April Last Reported Quarter: 01/01/25 Next Expected EPS Date: 08/04/25 Share - Related Items Shares Outstanding: 45.76 Most Recent Split Date: (:1) Beta: 0.44 Market Capitalization: $59.95 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.08 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.30 Price/Cash Flow: - Price / Sales: 3.44 EPS Growth vs. Year Ago Period: 25.00% vs. Previous Quarter: 14.29% Sales Growth vs. Year Ago Period: -5.97% vs. Previous Quarter: -3.50% ROE 04/30/25 - - 01/31/25 - -88.87 10/31/24 - -73.74 ROA 04/30/25 - - 01/31/25 - -49.26 10/31/24 - -42.68 Current Ratio 04/30/25 - - 01/31/25 - 2.32 10/31/24 - 1.01 Quick Ratio 04/30/25 - - 01/31/25 - 2.11 10/31/24 - 0.85 Operating Margin 04/30/25 - - 01/31/25 - -115.69 10/31/24 - -114.50 Net Margin 04/30/25 - - 01/31/25 - -190.76 10/31/24 - -114.50 Pre-Tax Margin 04/30/25 - - 01/31/25 - -211.85 10/31/24 - -125.51 Book Value 04/30/25 - - 01/31/25 - 0.57 10/31/24 - 0.83 Inventory Turnover 04/30/25 - - 01/31/25 - 5.94 10/31/24 - 5.59 Debt-to-Equity 04/30/25 - - 01/31/25 - 0.45 10/31/24 - 0.36 Debt-to-Capital 04/30/25 - - 01/31/25 - 30.91 10/31/24 - 26.31

Powered by Zacks Investment Research ©